The Presence of Genomic Instability in Cerebrospinal Fluid in Patients with Meningeal Metastasis

References

• Cui JZ, He JY, Li Q, et al. Advancements in diagnosis and treatment of meningeal carcinomatosis in solid cancer. Neurol Neuroimmunol Neuroinflamm. 2017;4(9):167. doi:10.20517/2347-8659.2017.26
   Google Scholar
• Nevel KS, DiStefano N, Lin X, et al. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer. Neuro-Oncology. 2020;22(5):675–683. doi:10.1093/neuonc/noz20832352148
   PubMed Web of Science ®Google Scholar
• Nagpal S, Riess J, Wakelee H. Treatment of leptomeningeal spread of NSCLC: a continuing challenge. Curr Treat Options Oncol. 2012;13(4):491–504. doi:10.1007/s11864-012-0206-422836285
   PubMed Web of Science ®Google Scholar
• Leal T, Chang JE, Mehta M, Robins HI. Leptomeningeal metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev. 2011;7(4):319–327. doi:10.2174/15733941179764259723251128
   PubMedGoogle Scholar
• Lee E, Keam B, Kim DW, et al. Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer. J Thorac Oncol. 2013;8(8):1069–1074. doi:10.1097/JTO.0b013e318294c8e823804027
   PubMed Web of Science ®Google Scholar
• Kuiper JL, Hendriks LE, van der Wekken AJ, et al. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: a retrospective cohort analysis. Lung Cancer. 2015;89(3):255–261. doi:10.1016/j.lungcan.2015.05.02326117231
   PubMed Web of Science ®Google Scholar
• Quintanal-Villalonga Á, Chan JM, Yu HA, et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat Rev Clin Oncol. 2020;17(6):360–371. doi:10.1038/s41571-020-0340-z32152485
   PubMed Web of Science ®Google Scholar
• Duijf PHG, Nanayakkara D, Nones K, Srihari S, Kalimutho M, Khanna KK. Mechanisms of genomic instability in breast cancer. Trends Mol Med. 2019;25(7):595–611. doi:10.1016/j.molmed.2019.04.00431078431
   PubMed Web of Science ®Google Scholar
• Bezak B, Lehrke H, Elvin J, Gay L, Schembri-Wismayer D, Viozzi C. Comprehensive genomic profiling of central giant cell lesions identifies clinically relevant genomic alterations. J Oral Maxillofac Surg. 2017;75(5):955–961. doi:10.1016/j.joms.2016.10.02727883876
   PubMed Web of Science ®Google Scholar
• Woodhouse R, Li M, Hughes J, et al. Clinical and analytical validation of foundationone liquid CDx, a novel 324-gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS One. 2020;15(9):e0237802. doi:10.1371/journal.pone.023780232976510
   PubMed Web of Science ®Google Scholar
• De Mattos-arruda L, Mayor R, Ng CKY, et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun. 2015;6(1):8839. doi:10.1038/ncomms983926554728
   PubMed Web of Science ®Google Scholar
• Zheng MM, Li YS, Jiang BY, et al. Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in ALK-rearranged NSCLC. J Thorac Oncol. 2019;14(5):924–932. doi:10.1016/j.jtho.2019.01.00730659989
   PubMed Web of Science ®Google Scholar
• Shao Q, Jiang Y, Wu J. [Whole-genome sequencing and its application in the research and diagnoses of genetic diseases]. Yi Chuan. 2014;36(11):1087–1098. Chinese.25567867
   PubMedGoogle Scholar
• Taylor AM, Shih J, Ha G, et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell. 2018;33:676–689.e673.29622463
   PubMed Web of Science ®Google Scholar
• Chiang CL, Lee CC, Huang HC, et al. Utility of cerebrospinal fluid cell-free DNA in patients with EGFR-mutant non-small-cell lung cancer with leptomeningeal metastasis. Target Oncol. 2021;16(2):207–214. doi:10.1007/s11523-021-00791-933566300
   PubMed Web of Science ®Google Scholar
• McEwen AE, Leary SES, Lockwood CM. Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors. Frontiers in cell and developmental biology. 2020;8:45.32133357
   PubMed Web of Science ®Google Scholar
• Xin ZH, Xiaoqin LI, Xiuli WA. The treatment for acquired drug resistance of clinical characteristics of patients with non-small cell lung cancer. Chin Oncol. 2015;25:222–229.
   Google Scholar
• Gutenberg A, Gerdes JS, Jung K, et al. High chromosomal instability in brain metastases of colorectal carcinoma. Cancer Genet Cytogenet. 2010;198(1):47–51. doi:10.1016/j.cancergencyto.2009.12.00620303014
   PubMedGoogle Scholar
• Nakao K, Mehta KR, Fridlyand J, et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis. 2004;25(8):1345–1357. doi:10.1093/carcin/bgh13415001537
   PubMed Web of Science ®Google Scholar
• Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol. 2008;180(4):665–672. doi:10.1083/jcb.20071202918283116
   PubMed Web of Science ®Google Scholar
• Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786–791. doi:10.1126/science.123245823258413
   PubMed Web of Science ®Google Scholar
• Abe T, Barber GN. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1. J Virol. 2014;88(10):5328–5341. doi:10.1128/JVI.00037-1424600004
   PubMed Web of Science ®Google Scholar
• Bakhoum SF, Ngo B, Laughney AM, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553(7689):467–472. doi:10.1038/nature2543229342134
   PubMed Web of Science ®Google Scholar
• Liao YC, Ruan JW, Lua I, et al. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling. Oncogene. 2012;31(25):3086–3097. doi:10.1038/onc.2011.47622002306
   PubMed Web of Science ®Google Scholar
• Riess JW, Nagpal S, Iv M, et al. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era. Clin Lung Cancer. 2014;15(3):202–206. doi:10.1016/j.cllc.2013.12.00924524822
   PubMed Web of Science ®Google Scholar
• Li JR, Zhang Y, Zheng JL. Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation. J Thorac Dis. 2016;8(7):1504–1512. doi:10.21037/jtd.2016.05.7027499937
   PubMed Web of Science ®Google Scholar
• Nishii Y, Hataji O, Ito K, et al. Efficacy of osimertinib in a patient with non-small cell lung cancer harboring epithelial growth factor receptor exon 19 deletion/T790M mutation, with poor performance status. Mol Clin Oncol. 2018;8(2):246–249. doi:10.3892/mco.2017.152229399354
   PubMed Web of Science ®Google Scholar
• Shi YK, Wang L, Han BH, et al. First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a Phase 3, Open-Label, Randomized Study. Ann Oncol. 2017;28(10):2443–2450. doi:10.1093/annonc/mdx35928945850
   PubMed Web of Science ®Google Scholar
• Soria JC, Ohe Y, Vansteenkiste J, et al. Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer. N Engl J Med. 2018;378(2):113–125. doi:10.1056/NEJMoa171313729151359
   PubMed Web of Science ®Google Scholar
• Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510–514. doi:10.1016/j.ijrobp.2007.06.07417931798
   PubMed Web of Science ®Google Scholar
• Clarke JL, Pao W, Wu N, Miller VA, Lassman AB. High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer. J Neurooncol. 2010;99(2):283–286. doi:10.1007/s11060-010-0128-620146086
   PubMed Web of Science ®Google Scholar
• Clementz AG, Osipo C. Notch-1 activates ErbB-2 through a PEA3-dependent mechansim. Cancer Res. 2009;69:6015.19638593
   PubMed Web of Science ®Google Scholar
• Antoni D, Noël G. [Radiotherapy of brain metastases according to the GPA score (graded prognostic assessment)]. Cancer Radiother. 2013;17(5–6):424–427. Dutch. doi:10.1016/j.canrad.2013.06.03023973456
   PubMed Web of Science ®Google Scholar